By using a thrombin generation test with TM, alongside assessments of VWF antigen and ADAMTS-13 activity, we seek to investigate the extent of coagulation abnormalities and endothelial dysfunction in PCS patients. The gene discussed is VWF; the disease is endothelial dysfunction.